skip to main content

Our M&A lawyers are among the most experienced and effective in the world. We represent many of the world's largest publicly traded and privately held companies, as well as leading private equity firms on their most important mergers, acquisitions and takeover transactions.

Amedisys to Combine With Option Care Health in $9.7 Billion Deal

Paul, Weiss is advising Amedisys, Inc. in its combination with Option Care Health, Inc. in an all-stock transaction that values the combined company at $9.7 billion. The combination of Amedisys' home health, hospice, palliative and high-acuity care services with Option Care Health’s complementary home and alternate site infusion services will create a scaled, national platform for home and alternate site care.

Upon closing, stockholders of Option Care Health will own approximately 64.5% of the combined company, and Amedisys stockholders will own approximately 35.5%. The transaction is expected to close in the second half of 2023, subject to customary closing conditions and regulatory approvals.

The Paul, Weiss team is led by M&A partners Kyle Seifried and Krishna Veeraraghavan, and includes, among others, corporate partner Christopher Cummings and counsel Steve Centa and Frances Mi; executive compensation partners Jean McLoughlin and Rebecca Coccaro, and counsel Sasha Belinkie; litigation partners Geoffrey Chepiga, Joshua Soven and Andrew Finch, and counsel Steven Herzog and Jared Nagley; tax partner Brian Krause; intellectual property partner Jonathan Ashtor and counsel Marisa Geiger; real estate partner Peter Fisch; antitrust counsel Marta Kelly; and environmental counsel William O'Brien.

© 2024 Paul, Weiss, Rifkind, Wharton & Garrison LLP

Privacy Policy